MCK Q3 2023 Earnings — McKesson Corporation Revenue & Financial Results | Market Cap Arena

MCKMcKesson Corporation

$115B

Q3 2023 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$70.5B+2.7% YoY

Gross Profit

$3.0B4.2% margin

Operating Income

$1.1B1.6% margin

Net Income

$1.1B1.5% margin

EPS (Diluted)

$7.65

QoQ Revenue Growth

+0.5%

Cash Flow

Operating Cash Flow

$1.7B

Free Cash Flow

$1.5B

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$62.7B

Total Liabilities

$64.8B

Stockholders' Equity

-$2.5B

Cash & Equivalents

$2.8B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$70.5B	$68.6B	+2.7%
Gross Profit	$3.0B	$3.3B	-10.6%
Operating Income	$1.1B	$323M	+253.6%
Net Income	$1.1B	-$7M	+15514.3%

Revenue Segments

U.S. Pharmaceutical Segment

$61.9B88%

International Segment

$4.4B6%

Medical-Surgical Solutions Segment

$3.0B4%

Prescription Technology Solutions

$1.1B2%